Attenuated liver progenitor (oval) cell and fibrogenic responses to the choline deficient, ethionine supplemented diet in the BALB/c inbred strain of mice

Journal of Hepatology

Volumn 46, Issue 1, 2007, Pages 134-141

  Knight, Belinda ^a,b   Akhurst, Barbara ^b,c   Matthews, Vance B ^b,c   Ruddell, Richard G ^d   Ramm, Grant A ^d   Abraham, Lawrence J ^b   Olynyk, John K ^a,b   Yeoh, George C ^b,c  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^c UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^d QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

Author keywords

Fibrosis; Hepatic stellate cell; Interferon ; Liver regeneration; Progenitor cell

Indexed keywords

AMINOTRANSFERASE; CHOLINE; CYTOKINE; ETHIONINE; GAMMA INTERFERON;

AMINOTRANSFERASE BLOOD LEVEL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARCINOGENICITY; CELL ACTIVATION; CELL PROLIFERATION; CELL REGENERATION; CELLULAR IMMUNITY; CONTROLLED STUDY; DIET SUPPLEMENTATION; FIBROGENESIS; IMMUNE RESPONSE; INBRED STRAIN; INFLAMMATION; LIVER CELL; LIVER FIBROSIS; LIVER INJURY; MORTALITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; STEM CELL; TH1 CELL;

ANIMALS; APOPTOSIS; CELL PROLIFERATION; CHOLINE DEFICIENCY; CYTOKINES; DIETARY SUPPLEMENTS; ETHIONINE; HEPATOCYTES; INTERFERON TYPE II; LIVER CIRRHOSIS; LIVER REGENERATION; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; SPECIES SPECIFICITY; STEM CELLS; TH1 CELLS;

EID: 34548786662     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2006.08.015     Document Type: Article

References (31)

1. Alison M., Golding M., Lalani el N., and Sarraf C. Wound healing in the liver with particular reference to stem cells. Philos Trans R Soc Lond B Biol Sci 353 (1998) 877-894
2. Lowes K.N., Croager E.J., Olynyk J.K., Abraham L.J., and Yeoh G.C. Oval cell-mediated liver regeneration: role of cytokines and growth factors. J Gastroenterol Hepatol 18 (2003) 4-12
3. Roskams T.A., Libbrecht L., and Desmet V.J. Progenitor cells in diseased human liver. Semin Liver Dis 23 (2003) 385-396
4. Lowes K.N., Brennan B.A., Yeoh G.C., and Olynyk J.K. Oval cell numbers in human chronic liver diseases are directly related to disease severity. Am J Pathol 154 (1999) 537-541
5. Libbrecht L., De Vos R., Cassiman D., Desmet V., Aerts R., and Roskams T. Hepatic progenitor cells in hepatocellular adenomas. Am J Surg Pathol 25 (2001) 1388-1396
6. Knight B., and Yeoh G.C. TNF/LTalpha double knockout mice display abnormal inflammatory and regenerative responses to acute and chronic liver injury. Cell Tissue Res 319 (2005) 61-70
7. Knight B., Matthews V.B., Akhurst B., Croager E.J., Klinken E., Abraham L.J., Olynyk J.K., et al. Liver inflammation and cytokine production,but not acute phase protein synthesis, accompany the adult liver progenitor (oval) cell response to chronic liver injury. Immunol Cell Biol 83 (2005) 364-374
8. Davies R, Knight B, Tian Y-W, Yeoh G, Olynyk JK. Hepatic progenitor cell response is attenuated by to the choline deficient, ethionine supplemented diet model of murine liver injury is attenuated by the administration of a selective cyclooxygenase 2 inhibitor. Carcinogenesis 2006.
9. Nagy P., Kiss A., Schnur J., and Thorgeirsson S.S. Dexamethasone inhibits the proliferation of hepatocytes and oval cells but not bile duct cells in rat liver. Hepatology 28 (1998) 423-429
10. Akhurst B., Matthews V., Husk K., Smyth M.J., Abraham L.J., and Yeoh G.C. Differential lymphotoxin-beta and interferon gamma signaling during mouse liver regeneration induced by chronic and acute injury. Hepatology 41 (2005) 327-335
11. Knight B., Yeoh G.C., Husk K.L., Ly T., Abraham L.J., Yu C., Rhim J.A., et al. Impaired preneoplastic changes and liver tumor formation in tumor necrosis factor receptor type 1 knockout mice. J Exp Med 192 (2000) 1809-1818
12. Bisgaard H.C., Muller S., Nagy P., Rasmussen L.J., and Thorgeirsson S.S. Modulation of the gene network connected to interferon-gamma in liver regeneration from oval cells. Am J Pathol 155 (1999) 1075-1085
13. Sobue S., Nomura T., Ishikawa T., Ito S., Saso K., Ohara H., Joh T., et al. Th1/Th2 cytokine profiles and their relationship to clinical features in patients with chronic hepatitis C virus infection. J Gastroenterol 36 (2001) 544-551
14. Song K., Coleman R.A., Alber C., Ballas Z.K., Waldschmidt T.J., Mortari F., LaBrecque D.R., et al. TH1 cytokine response of CD57+ T-cell subsets in healthy controls and patients with alcoholic liver disease. Alcohol 24 (2001) 155-167
15. Jiang R., Feng X., Guo Y., Lu Q., Hou J., Luo K., and Fu N. T helper cells in patients with chronic hepatitis B virus infection. Chin Med J (Engl) 115 (2002) 422-424
16. Karupiah G. Type 1 and type 2 cytokines in antiviral defense. Vet Immunol Immunopathol 63 (1998) 105-109
17. Akhurst B., Croager E.J., Farley-Roche C.A., Ong J.K., Dumble M.L., Knight B., and Yeoh G.C. A modified choline-deficient, ethionine-supplemented diet protocol effectively induces oval cells in mouse liver. Hepatology 34 (2001) 519-522
18. Junqueira L.C., Bignolas G., and Brentani R.R. Picrosirius staining plus polarization microscopy, a specific method for collagen detection in tissue sections. Histochem J 11 (1979) 447-455
19. Knight B., Yeap B.B., Yeoh G.C., and Olynyk J.K. Inhibition of adult liver progenitor (oval) cell growth and viability by an agonist of the peroxisome proliferator activated receptor (PPAR) family member gamma, but not alpha or delta. Carcinogenesis (2005)
20. Kofman A.V., Morgan G., Kirschenbaum A., Osbeck J., Hussain M., Swenson S., and Theise N.D. Dose- and time-dependent oval cell reaction in acetaminophen-induced murine liver injury. Hepatology 41 (2005) 1252-1261
21. Bridle K.R., Crawford D.H., and Ramm G.A. Identification and characterization of the hepatic stellate cell transferrin receptor. Am J Pathol 162 (2003) 1661-1667
22. Dumble M.L., Croager E.J., Yeoh G.C., and Quail E.A. Generation and characterization of p53 null transformed hepatic progenitor cells: oval cells give rise to hepatocellular carcinoma. Carcinogenesis 23 (2002) 435-445
23. Matthews V.B., Knight B., Tirnitz-Parker J.E., Boon J., Olynyk J.K., and Yeoh G.C. Oncostatin M induces an acute phase response but does not modulate the growth or maturation-status of liver progenitor (oval) cells in culture. Exp Cell Res 306 (2005) 252-263
24. Liu L., Zhou X., Liu H., Xiang L., and Yuan Z. CpG motif acts as a 'danger signal' and provides a T helper type 1-biased microenvironment for DNA vaccination. Immunology 115 (2005) 223-230
25. Shi Z., Wakil A.E., and Rockey D.C. Strain-specific differences in mouse hepatic wound healing are mediated by divergent T helper cytokine responses. Proc Natl Acad Sci USA 94 (1997) 10663-10668
26. Mizuhara H., Kuno M., Seki N., Yu W.G., Yamaoka M., Yamashita M., Ogawa T., et al. Strain difference in the induction of T-cell activation-associated, interferon gamma-dependent hepatic injury in mice. Hepatology 27 (1998) 513-519
27. Baroni G.S., D'Ambrosio L., Curto P., Casini A., Mancini R., Jezequel A.M., and Benedetti A. Interferon gamma decreases hepatic stellate cell activation and extracellular matrix deposition in rat liver fibrosis. Hepatology 23 (1996) 1189-1199
28. Rockey D.C., Maher J.J., Jarnagin W.R., Gabbiani G., and Friedman S.L. Inhibition of rat hepatic lipocyte activation in culture by interferon-gamma. Hepatology 16 (1992) 776-784
29. Sakaida I., Uchida K., Matsumura Y., and Okita K. Interferon gamma treatment prevents procollagen gene expression without affecting transforming growth factor-beta1 expression in pig serum-induced rat liver fibrosis in vivo. J Hepatol 28 (1998) 471-479
30. Czaja M.J., Weiner F.R., Takahashi S., Giambrone M.A., van der Meide P.H., Schellekens H., Biempica L., et al. Gamma-interferon treatment inhibits collagen deposition in murine schistosomiasis. Hepatology 10 (1989) 795-800
31. Clouston A.D., Powell E.E., Walsh M.J., Richardson M.M., Demetris A.J., and Jonsson J.R. Fibrosis correlates with a ductular reaction in hepatitis C: roles of impaired replication, progenitor cells and steatosis. Hepatology 41 (2005) 809-818